Loading...
Please wait, while we are loading the content...
Thymoquinone-loaded mesenchymal stem cell-derived exosome as an efficient nano-system against breast cancer cells.
| Content Provider | Europe PMC |
|---|---|
| Author | Ebrahimian, Mahboubeh Hashemi, Maryam Etemad, Leila Salmasi, Zahra |
| Abstract | Objective(s):Exosomes became the subject of extensive research in drug delivery approach due to their potential applicability as therapeutic tools for cancer therapy. Thymoquinone (Tq) is an anti-cancer agent due to its great anti-proliferative effect. However, poor solubility and weak bioavailability restrict its therapeutic applications. In this study, exosomes secreted from human adipocyte-derived mesenchymal stem cells (AdMSCs) were isolated and the efficacy of a novel encapsulation method for loading of Tq was investigated. Finally, the cytotoxic effect of Tq incorporated exosomes against cancer cells was evaluated.Materials and Methods:Exosomes secreted from AdMSCs were isolated via ultracentrifugation and characterized by electron microscopy and western blotting. Then, through a novel encapsulation approach, Tq was loaded into exosomes by the combination of three methods including incubation, freeze-thawing, and surfactant treatment. Then, the encapsulation efficiency, in vitro cellular uptake, and cytotoxicity of Tq incorporated exosomes (Tq@EXOs) in MCF7 and L929 cells were estimated. Results:Tq loading into exosomes through our novel method caused a significant improvement in encapsulation efficiency of about 60%. The fluorescent microscopy and flow cytometry outcomes indicated the efficient uptake of Tq@EXOs-FITC by cells throughout 4 hr. Furthermore, MTT results displayed the ability of Tq@EXOs in effectively decreasing the cell viability of MCF7 without causing any obvious cytotoxicity on L929 as normal cells.Conclusion:The results suggest that our approach provides effective loading of Tq into exosomes which offer a valuable and safe platform for drug delivery to cancer cells thus having a great potential for clinical studies. |
| ISSN | 20083866 |
| Journal | Iranian Journal of Basic Medical Sciences |
| Volume Number | 25 |
| PubMed Central reference number | PMC9320205 |
| Issue Number | 6 |
| PubMed reference number | 35949303 |
| e-ISSN | 20083874 |
| DOI | 10.22038/IJBMS.2022.64092.14116 |
| Language | English |
| Publisher | Mashhad University of Medical Sciences |
| Publisher Date | 2022-06-01 |
| Publisher Place | Mashhad, Iran |
| Access Restriction | Open |
| Rights License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| Subject Keyword | Adipose-derived mesenchymal stem cells Breast cancer Drug delivery system Exosome Thymoquinone |
| Content Type | Text |
| Resource Type | Article |
| Subject | Immunology and Microbiology Drug Discovery Clinical Biochemistry Biochemistry Biophysics |